The AGAVE-201 analysis found no significant bone health concerns with axatilimab in chronic GVHD, showing stable biomarkers and no increased fractures.
Amandeep Salhotra
Advertisement
Amandeep Salhotra, MD, is a hematologist-oncologist and an associate professor at City of Hope.
Articles by Amandeep Salhotra
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicare GLP-1 Bridge Launches, but Who Actually Qualifies?
2
FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review
3
Online GLP-1 Sellers Often Skip Clinician Oversight
4
340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs
5